Covid19

Unpersuaded by the data, FDA rejects cheap, generic SSRI as a Covid-19 drug – Endpoints News

Fluvoxamine, an SSRI already FDA-approved as an OCD treatment, appeared to show some hints of efficacy in Covid-19 too, leading University of …

Read more at endpts.com

Show More

Related Articles

Back to top button